年龄相关性黄斑变性(age-related macular degeneration,AMD)又称为老年性黄斑变性,常伴有进行性视力损害,严重影响老年人的生存质量,是全世界第三位不可逆性致盲眼病。虽然AMD目前尚未成为我国人群致盲的首要原因,但是随着社会的老龄化,AMD在我国的发病率也逐渐升高。近年来,国内外学者对AMD进行了大量深入的研究,对本病有了更进一步的认识,现就AMD目前有关的治疗方法及其进展做一综述。

Age-related macular degeneration(AMD),known as senile macular degeneration,which is often accompanied by progressive visual impairment,has serious impact on quality of life of the older,and is the world’s third irreversible blinding eye disease.Although AMD has not yet become the leading cause of blindness in Chinese,with the aging of society,incidence of AMD in China has gradually increased.In recent years,domestic and foreign scholars have done a lot of AMD-depth research on this disease and have a further understanding about it,so we summarize the treatment of AMD at present.

R774.5